Last updated on February 2018

Lonquek for Autologous Stem Cell Mobilization


Brief description of study

The aim of this study is to evaluate the efficacy and tolerability of Lonquek which is a pegylated (long-acting) version of Filgrastim recombinant human G-CSF (G-CSF) in mobilizing sufficient number of stem cells for autologous stem cell transplantation in patients with lymphoma and multiple myeloma.

Clinical Study Identifier: NCT02488382

Find a site near you

Start Over